No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
OTLK Outlook Therapeutics
- 8.430
- +0.240+2.93%
Close Apr 26 16:00 ET
- 8.300
- -0.130-1.54%
Post 18:23 ET
196.41MMarket Cap-2107P/E (TTM)
8.500High8.135Low120.91KVolume8.220Open8.190Pre Close1.01MTurnover1.09%Turnover RatioLossP/E (Static)23.30MShares40.60052wk High-8.07P/B93.29MFloat Cap4.00452wk Low--Dividend TTM11.07MShs Float219.200Historical High--Div YieldTTM4.46%Amplitude4.004Historical Low8.367Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Outlook Therapeutics Files to Sell 2.78M Shares of Common Stock for Holders
Marriott Vacations, Carrols Restaurant Group, and More Stocks See Action From Activist Investors -- Barrons.com
These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequen
Express News | Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million
Express News | Outlook Therapeutics Files Prospectus Supplement Related To Offer, Sale Of Up To $93.7M Of Common Stock That May Be Sold Under Sales Agreement
Express News | Outlook Therapeutics - Files Prospectus Supplement Related to Offer, Sale of up to $93.7 Mln of Common Stock That May Be Sold Under Sales Agreement
Insiders Are Piling Into These 10 Healthcare Stocks in 2024
Comments
Update
$Outlook Therapeutics(OTLK.US$ Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million
4
2
Continues its climb
Will reach 15.00 by the end of the week. $Airship AI(AISP.US$
$Outlook Therapeutics(OTLK.US$ is another.
$Outlook Therapeutics(OTLK.US$ is another.
3
Don’t disappoint me sweetie! Hehehe
$Outlook Therapeutics(OTLK.US$ Just keep slowly walking up up up! been a nice uptrend for a few days now!
1
Again! Wish I had faith in analysts PT’s Hehehe
$Outlook Therapeutics(OTLK.US$ BTIG Upgrades Outlook Therapeutics to Buy, Announces $50 Price Target
Therapeutics Company Secures Positive Opinion For AMD Treatment
A New Dawn in Treating Wet Age-Related Macular Degeneration: The Groundbreaking Approval of ONS-5010.
In an era where medical advancements are pivotal to enhancing quality of life, a significant breakthrough has been made in the treatment of wet age-related macular degeneration (AMD), a leading cause of vision loss among the elderly. Outlook Therapeutics, Inc. has received a positive opinion from the European Union's Committee for Me...
In an era where medical advancements are pivotal to enhancing quality of life, a significant breakthrough has been made in the treatment of wet age-related macular degeneration (AMD), a leading cause of vision loss among the elderly. Outlook Therapeutics, Inc. has received a positive opinion from the European Union's Committee for Me...
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Sorbet : What does this mean for the share price? Do you have a price prediction for this year
TrytosaveabitOP Sorbet: I expect a move up because of the closing. Not sure how much/soon! I don’t like to guess at yearly targets! To many variables. But I wouldn’t be surprised buy 30+